메뉴 건너뛰기




Volumn 11, Issue 4, 2005, Pages

Angiokeratoma corporis diffusum (Fabry disease)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE;

EID: 30144433770     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (9)
  • 1
    • 7944222473 scopus 로고    scopus 로고
    • Vascular anomalies and tumors of skin and subcutaneous tissues
    • Freedberg IM, et al., eds. New York: McGraw-Hill
    • Grevelink SV, Mulliken JB. Vascular anomalies and tumors of skin and subcutaneous tissues. In Freedberg IM, et al., eds. Dermatology in General Medicine. 6th ed. New York: McGraw-Hill; 2003:1015
    • (2003) Dermatology in General Medicine. 6th Ed. , pp. 1015
    • Grevelink, S.V.1    Mulliken, J.B.2
  • 2
    • 30144432192 scopus 로고    scopus 로고
    • Fabry disease: Alpha-galactosidase A deficiency (angiokeratoma corporis diffusum universale)
    • Freedberg IM, et al., eds. New York: McGraw-Hill
    • Desnick RJ, Banikazemi M. Fabry disease: alpha-galactosidase A deficiency (angiokeratoma corporis diffusum universale). In Freedberg IM, et al., eds. Dermatology in General Medicine. 6th ed. New York: McGraw-Hill; 2003:1474
    • (2003) Dermatology in General Medicine. 6th ed. , pp. 1474
    • Desnick, R.J.1    Banikazemi, M.2
  • 3
    • 1842506629 scopus 로고    scopus 로고
    • Misdiagnosis of Fabry disease: Importance of biochemical confirmation of clinical or pathologic suspicion
    • Linthorst GE, et al. Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathologic suspicion. Br J Dermatol 2004; 150: 575
    • (2004) Br J Dermatol , vol.150 , pp. 575
    • Linthorst, G.E.1
  • 4
    • 0036408781 scopus 로고    scopus 로고
    • Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria
    • Vargas-Diez E, et al. Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria. Br J Dermatol 2002; 147: 760
    • (2002) Br J Dermatol , vol.147 , pp. 760
    • Vargas-Diez, E.1
  • 5
    • 0023411044 scopus 로고
    • Widespread angiokeratomas without evidence of metabolic disease
    • Marsden J, Allen R. Widespread angiokeratomas without evidence of metabolic disease (Letter). Arch Dermatol 1987; 123: 1125
    • (1987) Arch Dermatol , vol.123 , pp. 1125
    • Marsden, J.1    Allen, R.2
  • 6
    • 0036796351 scopus 로고    scopus 로고
    • Fabry disease: Recent advances in enzyme replacement therapy
    • Germain DP. Fabry disease: recent advances in enzyme replacement therapy. Expert Opin Investig Drugs 2002; 11:1467 7.
    • (2002) Expert Opin Investig Drugs , vol.11 , pp. 14677
    • Germain, D.P.1
  • 7
    • 3142554529 scopus 로고    scopus 로고
    • Long-term safety and efficacy of enzyme replacement therapy for Fabry disease
    • Wilcox WR, et al. Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 2004;75:65
    • (2004) Am J Hum Genet , vol.75 , pp. 65
    • Wilcox, W.R.1
  • 8
    • 1842610986 scopus 로고    scopus 로고
    • Successful treatment of angiokeratoma with potassium tritanyl phosphate laser
    • Correspondence
    • Gorse SJ, et al. Successful treatment of angiokeratoma with potassium tritanyl phosphate laser (Correspondence). Br J Dermatol 2004;150:620
    • (2004) Br J Dermatol , vol.150 , pp. 620
    • Gorse, S.J.1
  • 9
    • 0028910732 scopus 로고
    • Argon laser treatment of cutaneous multiple angiokeratomas
    • Occella C, et al. Argon laser treatment of cutaneous multiple angiokeratomas. Derm Surg 1995;21:170
    • (1995) Derm Surg , vol.21 , pp. 170
    • Occella, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.